184 related articles for article (PubMed ID: 8381800)
1. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
[TBL] [Abstract][Full Text] [Related]
2. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
[TBL] [Abstract][Full Text] [Related]
3. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
Grottoli S; Giordano R; Maccagno B; Pellegrino M; Ghigo E; Arvat E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
[TBL] [Abstract][Full Text] [Related]
4. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
[TBL] [Abstract][Full Text] [Related]
5. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
[TBL] [Abstract][Full Text] [Related]
6. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of naloxone-stimulated adrenocorticotropin release by alprazolam in myotonic dystrophy patients.
Joyner JM; Grice JE; Hockings GI; Torpy DJ; Crosbie GV; Walters MM; Jackson RV
J Neuroendocrinol; 1998 May; 10(5):391-5. PubMed ID: 9663654
[TBL] [Abstract][Full Text] [Related]
8. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
Vicennati V; Ceroni L; Gagliardi L; Pagotto U; Gambineri A; Genghini S; Pasquali R
J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications.
Kalogeras KT; Calogero AE; Kuribayiashi T; Khan I; Gallucci WT; Kling MA; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1990 May; 70(5):1462-71. PubMed ID: 2159487
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.
Alexander SL; Irvine CH; Donald RA
Front Neuroendocrinol; 1996 Jan; 17(1):1-50. PubMed ID: 8788568
[TBL] [Abstract][Full Text] [Related]
11. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ; Jackson RV; Grice JE; Hockings GI; Crosbie GV; Walters MM
Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):157-61. PubMed ID: 8039271
[TBL] [Abstract][Full Text] [Related]
12. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
Korbonits M; Kaltsas G; Perry LA; Putignano P; Grossman AB; Besser GM; Trainer PJ
J Clin Endocrinol Metab; 1999 Jul; 84(7):2489-95. PubMed ID: 10404825
[TBL] [Abstract][Full Text] [Related]
13. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses.
Alexander SL; Irvine CH
Endocrinology; 1995 Nov; 136(11):5139-47. PubMed ID: 7588252
[TBL] [Abstract][Full Text] [Related]
14. The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam.
Rohrer T; von Richthofen V; Schulz C; Beyer J; Lehnert H
Horm Metab Res; 1994 Apr; 26(4):200-6. PubMed ID: 8082875
[TBL] [Abstract][Full Text] [Related]
15. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the central noradrenergic and adrenergic pathways activate the hypothalamic-pituitary-adrenal axis in the sheep.
Liu JP; Clarke IJ; Funder JW; Engler D
Endocrinology; 1991 Jul; 129(1):200-9. PubMed ID: 1647297
[TBL] [Abstract][Full Text] [Related]
17. Naloxone-induced activation of the hypothalamic-pituitary-adrenal axis in suspected central adrenal insufficiency.
Blevins LS; Dobs AS; Wand GS
Am J Med Sci; 1994 Sep; 308(3):167-70. PubMed ID: 8074133
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the hypothalamic-pituitary-adrenal axis during water deprivation.
Aguilera G; Lightman SL; Kiss A
Endocrinology; 1993 Jan; 132(1):241-8. PubMed ID: 8380375
[TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma adrenocorticotropin, hypothalamic opioid tone, and plasma leptin.
Wand GS; Schumann H
J Clin Endocrinol Metab; 1998 Jun; 83(6):2138-42. PubMed ID: 9626152
[TBL] [Abstract][Full Text] [Related]
20. Confirmation that offspring from families with alcohol-dependent individuals have greater hypothalamic-pituitary-adrenal axis activation induced by naloxone compared with offspring without a family history of alcohol dependence.
Wand G; McCaul ME; Gotjen D; Reynolds J; Lee S
Alcohol Clin Exp Res; 2001 Aug; 25(8):1134-9. PubMed ID: 11505044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
